PIONEST Trademark

Trademark Overview


On Wednesday, May 1, 2013, a trademark application was filed for PIONEST with the United States Patent and Trademark Office. The USPTO has given the PIONEST trademark a serial number of 85919955. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 2, 2017. This trademark is owned by Novartis AG. The PIONEST trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations ...
pionest

General Information


Serial Number85919955
Word MarkPIONEST
Filing DateWednesday, May 1, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 2, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2013

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 8, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Tuesday, January 3, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 2, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 31, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 30, 2016EXTENSION 5 GRANTED
Tuesday, May 24, 2016EXTENSION 5 FILED
Tuesday, May 24, 2016TEAS EXTENSION RECEIVED
Tuesday, December 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2015EXTENSION 4 GRANTED
Friday, November 20, 2015EXTENSION 4 FILED
Friday, November 20, 2015TEAS EXTENSION RECEIVED
Friday, May 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2015EXTENSION 3 GRANTED
Sunday, May 17, 2015EXTENSION 3 FILED
Wednesday, May 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, May 17, 2015TEAS EXTENSION RECEIVED
Thursday, January 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 14, 2015EXTENSION 2 GRANTED
Wednesday, November 19, 2014EXTENSION 2 FILED
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 19, 2014TEAS EXTENSION RECEIVED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 21, 2014EXTENSION 1 GRANTED
Wednesday, May 21, 2014EXTENSION 1 FILED
Wednesday, May 21, 2014TEAS EXTENSION RECEIVED
Tuesday, November 26, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 11, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2013ASSIGNED TO EXAMINER
Wednesday, May 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 4, 2013NEW APPLICATION ENTERED IN TRAM